COVID-19 international peer support program webinar series

COVID-19 international peer support program webinar series

A series of webinars delivered by volunteer medical and health specialists as part of the COVID-19 International Peer Support Program. 

For more information on the Peer Support Program, and to request support from peers in Australia, please visit the COVID-19 Peer Support Program website

Upcoming events

COVID-19 vaccination in patients with blood disorders

7.30pm 16 June 2021 (AEST) | Register

Coronavirus disease (COVID)‐19 is a respiratory disease caused by severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2). Patients with blood cancer require special considerations because of...

About the speaker

Associate Professor Dr Dipti Talaulikar is a Senior Staff Specialist in Clinical and Laboratory Haematology at Canberra Hospital. Her clinical and research interest in malignant haematology including Non-Hodgkin Lymphoma, Myeloma and Myeloproliferative Neoplasms has resulted in numerous publications. Her expertise ranges across Translational and Clinical Research, Genomics and Medical Education.

She is an Associate Professor at the Australian National University, chair of the Specialist Working Group (Haematology) at the National Blood Authority, a long-standing member of Myeloma Australia’s Medical and Scientific Advisor Group, and member of other leading cancer trial and research groups in Australia. 

Dr. Talaulikar contributes to medical workforce development and advocacy for equity of access to diagnostic tests and blood cancer treatments through leadership roles in organizations such as Royal College of Pathologists of Australasia (RCPA), National Blood Authority and Myeloma Australia. She is recognized as a key opinion leader (KOL) and is regularly invited to participate in Advisory Boards to provide guidance into clinical development of drugs, feedback into trial protocols and insights into research opportunities. She has authored both national and international clinical practice guidelines that have had a significant impact on cancer patient care.

Past events

No events are currently scheduled.